SCANGOS GEORGE A has filed 46 insider transactions across 3 companies since December 2022.
Most recent transaction: a grant/award of 1057 shares of AGILENT TECHNOLOGIES, INC. ($A) on March 19, 2026.
Activity breakdown: 0 open-market purchases and 12 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | AGILENT TECHNOLOGIES, INC. | $A | SCANGOS GEORGE A | Director | A | Common Stock | 1057 | $111.75 | 41,750.0470 | 285,000,000 | 2.60% | 0.00% |
| March 19, 2026 | AGILENT TECHNOLOGIES, INC. | $A | SCANGOS GEORGE A | Director | A | Common Stock | 2158 | $111.75 | 40,693.0470 | 285,000,000 | 5.60% | 0.00% |
| June 3, 2025 | Voyager Therapeutics, Inc. | $VYGR | SCANGOS GEORGE A | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 58,349,769 | 9999.99% | 0.04% |
| March 14, 2025 | AGILENT TECHNOLOGIES, INC. | $A | SCANGOS GEORGE A | Director | A | Common Stock | 1819 | $121.18 | 38,386.0740 | 291,000,000 | 4.97% | 0.00% |
| Feb. 24, 2025 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | S | Common Stock | 10056 | $9.45 | 3,215,258.0000 | 137,143,286 | 0.31% | 0.01% |
| Feb. 18, 2025 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | S | Common Stock | 10964 | $9.81 | 3,225,314.0000 | 0 | 0.34% | 0.00% |
| Oct. 23, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 598270 | $0.00 | 598,270.0000 | 0 | 9999.99% | 0.00% |
| Oct. 23, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 598270 | $0.00 | 2,084,548.0000 | 0 | 40.25% | 0.00% |
| Oct. 23, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 598270 | $0.00 | 2,084,548.0000 | 0 | 22.30% | 0.00% |
| Oct. 23, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 598270 | $0.00 | 2,084,548.0000 | 0 | 22.30% | 0.00% |
| June 5, 2024 | Voyager Therapeutics, Inc. | $VYGR | SCANGOS GEORGE A | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 57,117,046 | 9999.99% | 0.04% |
| May 30, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | A | Common Stock | 8000 | $0.00 | 3,834,548.0000 | 0 | 0.21% | 0.00% |
| May 30, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | AGILENT TECHNOLOGIES, INC. | $A | SCANGOS GEORGE A | Director | G | Common Stock | 3443 | $145.48 | 36,470.8700 | 296,000,000 | 8.63% | 0.00% |
| May 29, 2024 | AGILENT TECHNOLOGIES, INC. | $A | SCANGOS GEORGE A | Director | G | Common Stock | 3443 | $145.48 | 36,470.8700 | 296,000,000 | 10.42% | 0.00% |
| March 15, 2024 | AGILENT TECHNOLOGIES, INC. | $A | SCANGOS GEORGE A | Director | A | Common Stock | 1678 | $147.48 | 36,439.3550 | 296,000,000 | 4.83% | 0.00% |
| Feb. 26, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | S | Common Stock | 17722 | $11.65 | 3,826,548.0000 | 0 | 0.46% | 0.00% |
| Feb. 22, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | S | Common Stock | 10028 | $10.05 | 3,844,270.0000 | 0 | 0.26% | 0.00% |
| Feb. 16, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | S | Common Stock | 10878 | $10.24 | 3,871,170.0000 | 0 | 0.28% | 0.00% |
| Feb. 20, 2024 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | S | Common Stock | 16872 | $10.22 | 3,854,298.0000 | 0 | 0.44% | 0.00% |
| Oct. 17, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 1750000 | $0.00 | 2,132,048.0000 | 0 | 45.08% | 0.00% |
| Oct. 17, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 1750000 | $0.00 | 2,132,048.0000 | 0 | 458.06% | 0.00% |
| Oct. 17, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 1750000 | $0.00 | 382,048.0000 | 0 | 82.08% | 0.00% |
| Oct. 17, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 1750000 | $0.00 | 2,132,048.0000 | 0 | 458.06% | 0.00% |
| Sept. 15, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 1750000 | $0.00 | 2,098,419.0000 | 0 | 502.27% | 0.00% |
| Sept. 15, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 3500000 | $0.00 | 2,132,048.0000 | 0 | 62.14% | 0.00% |
| Sept. 15, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 1750000 | $0.00 | 3,848,419.0000 | 0 | 83.40% | 0.00% |
| Sept. 15, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 111644 | $0.00 | 2,098,419.0000 | 0 | 5.05% | 0.00% |
| Sept. 15, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 827151 | $0.00 | 2,098,419.0000 | 0 | 28.27% | 0.00% |
| Sept. 15, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 111644 | $0.00 | 2,098,419.0000 | 0 | 5.05% | 0.00% |
| Sept. 15, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | Director | J | Common Stock | 827151 | $0.00 | 2,098,419.0000 | 0 | 28.27% | 0.00% |
| June 6, 2023 | Voyager Therapeutics, Inc. | $VYGR | SCANGOS GEORGE A | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 42,161,326 | 9999.99% | 0.05% |
| May 9, 2023 | Voyager Therapeutics, Inc. | $VYGR | SCANGOS GEORGE A | Director | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 42,161,326 | 9999.99% | 0.10% |
| March 16, 2023 | AGILENT TECHNOLOGIES, INC. | $A | SCANGOS GEORGE A | Director | A | Common Stock | 1658 | $136.82 | 34,634.9180 | 0 | 5.03% | 0.00% |
| Feb. 23, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | S | Common Stock | 12631 | $25.97 | 5,774,757.0000 | 0 | 0.22% | 0.00% |
| Feb. 24, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | S | Common Stock | 4239 | $22.74 | 5,770,518.0000 | 0 | 0.07% | 0.00% |
| Feb. 24, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | S | Common Stock | 10880 | $23.56 | 5,759,638.0000 | 0 | 0.19% | 0.00% |
| Dec. 21, 2022 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | J | Common Stock | 49984 | $0.00 | 307,883.0000 | 0 | 19.38% | 0.00% |
| Jan. 18, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | J | Common Stock | 64930 | $0.00 | 3,729,868.0000 | 0 | 1.71% | 0.00% |
| Feb. 17, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | S | Common Stock | 9894 | $25.29 | 394,025.0000 | 0 | 2.45% | 0.00% |
| Jan. 18, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | J | Common Stock | 64930 | $0.00 | 376,169.0000 | 0 | 20.86% | 0.00% |
| Feb. 21, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | S | Common Stock | 11382 | $28.02 | 382,643.0000 | 0 | 2.89% | 0.00% |
| Feb. 21, 2023 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | S | Common Stock | 6474 | $28.80 | 376,169.0000 | 0 | 1.69% | 0.00% |
| Dec. 21, 2022 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | J | Common Stock | 49984 | $0.00 | 1,023,390.0000 | 0 | 4.66% | 0.00% |
| Dec. 21, 2022 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | J | Common Stock | 49984 | $0.00 | 307,883.0000 | 0 | 19.38% | 0.00% |
| Dec. 21, 2022 | Vir Biotechnology, Inc. | $VIR | SCANGOS GEORGE A | President and CEO | J | Common Stock | 49984 | $0.00 | 1,023,390.0000 | 0 | 4.66% | 0.00% |